Philip Tagari switch­es Am­gen's dis­cov­ery lab for in­sitro's ma­chine learn­ing tools; CEO Joaquin Du­a­to to chair J&J's board

In Feb­ru­ary, Philip Tagari will take a few days of re­tire­ment and then im­me­di­ate­ly re­turn to in­dus­try. He won’t be lead­ing the ther­a­peu­tics dis­cov­ery unit …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER